Pfizer
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings expectations. Reported EPS is $0.82, expectations were $0.516. P...
Pfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its stock...
Pfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied pharmaceutic...
Analyst ratings
62%
of 26 ratingsMore PFE News
Pfizer (PFE) beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday. The company reported $14.9 billion in revenue, d...
Loading... Loading... U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve o...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations On Wednesday, Pfizer I...
Pfizer PFE reported first-quarter 2024 adjusted earnings per share of 82 cents, which comfortably beat the Zacks Consensus Estimate of 56 cents per share. Earni...
Pfizer (PFE) shares tick up in pre-market trading — continuing into the green after the market open — after the pharmaceutical giant raised its full-year profit...
Global healthcare major Pfizer (NYSE:PFE) delivered impressive numbers for the first quarter with its EPS of $0.82 handily smashing estimates by a wide margin o...
Reported Revenue: $14.9 billion, a decrease of 20% year-over-year, falling short of estimates of $14.01 billion. Reported Net Income: $3.115 billion, down 44%...
